Trending



Why NAFDAC Fake Drug Seizures Protect Citizens

NAFDAC fake drug seizures burning of confiscated fake pharmaceuticals in Lagos

LAGOS, NIGERIA — Nigeria’s regulatory authorities have intensified their NAFDAC fake drug seizures, destroying counterfeit and substandard goods worth more than N1.5 trillion while securing 64 legal convictions between June 2025 and June 2026. Director-General Prof. Mojisola Adeyeye announced the enforcement figures on 7 September 2026, highlighting targeted market raids designed to purge toxic and falsified items from public circulation.

During major coordinated operations across key commercial hubs—including Idumota market in Lagos, Onitsha, and Ariaria International Market in Aba—agency inspectors confiscated 137 truckloads of substandard products while maintaining active surveillance over 47,830 registered facilities nationwide.

Convictions Driving the NAFDAC Fake Drug Seizures Momentum

Recent court judgements underscore a strict judicial push against pharmaceutical counterfeiting. Sentences obtained include a seven-year prison term for producing counterfeit antibiotics, a five-year term for falsifying Global Fund Artemether antimalarials, and one-year sentences for manufacturing fake ointments and condoms. Notably, counterfeit alcoholic beverages accounted for over half of all recent convictions.

Enforcement Category Recorded Volume / Judicial Action Notable Target Areas
Total Value Destroyed N1.5 Trillion Pharmaceuticals, Beverages, Water
Market Truckloads Confiscated 137 Truckloads Idumota, Onitsha, Ariaria Markets
Facilities Monitored 47,830 Facilities Nationwide Supply Chains
Maximum Sentence Obtained 7 Years Imprisonment Counterfeit Antibiotic Production

Uncovering Commercial Water Frauds in Major Cities

In addition to pharmaceutical raids, investigators uncovered three fraudulent bottling firms collecting empty, branded 19-litre water containers, refilling them with water from unapproved sources, and supplying them directly to major hotels and supermarkets.

The agency continues to petition lawmakers for harsher statutory penalties against counterfeiters while leveraging its “5+5” regulatory policy to drive marketing authorization holders toward domestic pharmaceutical manufacturing.

Why It Matters: Counterfeit medications cause widespread treatment failures and drug resistance; enforcement data reveals the severe health risks still threatening consumers on Nigerian retail shelves.

.

Source: Vanguard, 7 September 2026. 

Please follow and like us:

Leave a Reply

Your email address will not be published. Required fields are marked *